LIFECORE BIOMEDICAL, INC. Line of Credit, Current
LIFECORE BIOMEDICAL, INC. (LFCR) had Line of Credit, Current of $0 as of 2023-05-28, per its 10-K filed 2024-03-20.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:LinesOfCreditCurrent · last filed 2024-03-20
- 2023-05-28: Line of Credit, Current $0.00.
- 2023-02-26: Line of Credit, Current $0.00.
- 2022-11-27: Line of Credit, Current $48.00M.
- 2022-08-28: Line of Credit, Current $44.00M.
| Period end | Line of Credit, Current |
|---|---|
| 2023-05-28 | $0.00 10-K · filed 2024-03-20 |
| 2023-02-26 | $0.00 10-Q · filed 2023-06-02 |
| 2022-11-27 | $48.00M 10-K · filed 2024-03-20 |
| 2022-08-28 | $44.00M 10-K · filed 2024-03-20 |
| 2022-05-29 | $40.00M 10-K · filed 2024-03-20 |
| 2022-02-27 | $39.90M 10-K · filed 2024-03-20 |
| 2021-11-28 | $42.00M 10-K · filed 2024-03-20 |
| 2021-08-29 | $32.00M 10-K · filed 2024-03-20 |
| 2021-05-30 | $29.00M 10-K · filed 2024-03-20 |
| 2021-02-28 | $41.00M 10-K · filed 2024-03-20 |
| 2020-11-29 | $77.00M 10-K · filed 2024-03-20 |
| 2020-08-30 | $69.00M 10-K · filed 2024-03-20 |
| 2020-05-31 | $77.40M 10-K · filed 2021-07-29 |
| 2020-02-23 | $58.50M 10-Q · filed 2020-04-03 |
| 2019-11-24 | $61.50M 10-Q · filed 2020-01-02 |
| 2019-08-25 | $70.60M 10-Q · filed 2019-10-03 |
| 2019-05-26 | $52.00M 10-K · filed 2020-08-14 |
| 2019-02-24 | $44.00M 10-Q · filed 2019-04-04 |
| 2018-11-25 | $42.00M 10-Q · filed 2019-01-07 |
| 2018-08-26 | $39.00M 10-Q · filed 2018-10-05 |
| 2018-05-27 | $27.00M 10-K · filed 2019-08-01 |
| 2018-02-25 | $12.00M 10-Q · filed 2018-04-05 |
| 2017-11-26 | $10.00M 10-Q · filed 2018-01-05 |
| 2017-08-27 | $10.50M 10-Q · filed 2017-09-28 |
| 2017-05-28 | $3.00M 10-K · filed 2018-08-09 |
| 2016-11-27 | $1.50M 10-Q · filed 2017-01-05 |
| 2016-05-29 | $3.50M 10-K/A · filed 2018-03-15 |
| 2015-03-01 | $9.30M 10-Q · filed 2015-04-02 |
| 2014-11-30 | $5.00M 10-Q · filed 2015-01-09 |
| 2013-11-24 | $1.00M 10-Q · filed 2014-01-03 |
| 2013-08-25 | $1.05M 10-Q · filed 2013-09-26 |
| 2013-05-26 | $4.00M 10-K · filed 2014-08-01 |
| 2013-02-24 | $4.00M 10-Q · filed 2013-04-04 |
| 2012-11-25 | $7.50M 10-Q · filed 2013-01-04 |
| 2012-08-26 | $7.50M 10-Q/A · filed 2013-01-02 |
| 2012-05-27 | $11.67M 10-K · filed 2013-08-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B |